share_log

Travere Therapeutics Price Target Raised to $23.00/Share From $18.00 by Canaccord Genuity

Travere Therapeutics Price Target Raised to $23.00/Share From $18.00 by Canaccord Genuity

Travere Therapeutics的股票目標價格從18.00美元上調至23.00美元,由Canaccord Genuity給出。
道瓊斯 ·  09/10 11:15  · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論